Top Markets
#1 TENDIES TENDIES +47.80%
#2 Akedo Akedo +46.12%
#3 Threshold Network Threshold Network +40.90%
#4 Mubarak Mubarak +26.06%
#5 Cash Cat Cash Cat +20.18%
#6 Wrapped Aave Ethereum USDC Wrapped Aave Ethereum USDC +18.00%
#7 MultiversX MultiversX +16.96%
#8 Magma Finance Magma Finance +16.31%
#9 OSK OSK +16.18%
#10 Kite Kite +15.18%
Coin of the day
TENDIES TENDIES
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
TWi Biotechnology, Inc. TWi Biotechnology, Inc.

TWi Biotechnology, Inc.

6610
Kedudukan dalam Saham #17311
TWi Biotechnology, Inc. operates as a clinical-stage biopharmaceutical firm,... TWi Biotechnology, Inc. operates as a clinical-stage biopharmaceutical firm, concentrating on the development and sale of medications designed to address innate immunity disorders, primarily within Taiwan. The company's drug pipeline notably includes AC-203, which is currently undergoing Phase 2 clinical trials for various conditions such as epidermolysis bullosa simplex, epidermolysis bullosa, arthritis, gout, and diabetes mellitus. Additionally, AC-1101 is in Phase 1 trials for vitiligo treatment and is advancing through preclinical stages for atopic dermatitis, granuloma annulare, and other uncommon autoimmune skin diseases. TWi Biotechnology has also established a drug development collaboration with Hong Kong Winhealth Pharma Group Co., Limited, targeting the markets of Mainland China, Hong Kong, and Macao. Founded in 2010, the company is headquartered in Taipei, Taiwan.
Harga Saham
$1.21
Modal Pasaran
$248.41M
Perubahan (1 hari)
4.11%
Perubahan (1 tahun)
79.12%
Negara
TW
Perdagangan TWi Biotechnology, Inc. (6610)

Kategori

Healthcare
Hasil untuk TWi Biotechnology, Inc. (6610)
Hasil pada Sep 2026 TTM: 0
Menurut laporan kewangan terkini daripada TWi Biotechnology, Inc., hasil semasa syarikat (TTM) ialah 0. Pada tahun 2026, syarikat memperoleh hasil sebanyak 0 sama dengan hasil pada tahun 2026 iaitu 0. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi TWi Biotechnology, Inc. dari 2026 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH